166 related articles for article (PubMed ID: 12234859)
1. In vitro activities of newer quinolones against bacteroides group organisms.
Snydman DR; Jacobus NV; McDermott LA; Ruthazer R; Goldstein E; Finegold S; Harrell L; Hecht DW; Jenkins S; Pierson C; Venezia R; Rihs J; Gorbach SL
Antimicrob Agents Chemother; 2002 Oct; 46(10):3276-9. PubMed ID: 12234859
[TBL] [Abstract][Full Text] [Related]
2. Changing patterns of fluoroquinolone resistance among Bacteroides fragilis group organisms over a 6-year period (1997-2002).
Betriu C; Rodríguez-Avial I; Gómez M; Culebras E; Picazo JJ
Diagn Microbiol Infect Dis; 2005 Nov; 53(3):221-3. PubMed ID: 16243476
[TBL] [Abstract][Full Text] [Related]
3. Activities of new antimicrobial agents (trovafloxacin, moxifloxacin, sanfetrinem, and quinupristin-dalfopristin) against Bacteroides fragilis group: comparison with the activities of 14 other agents.
Betriu C; Gómez M; Palau ML; Sánchez A; Picazo JJ
Antimicrob Agents Chemother; 1999 Sep; 43(9):2320-2. PubMed ID: 10471590
[TBL] [Abstract][Full Text] [Related]
4. Comparative in vitro activities of clinafloxacin and trovafloxacin against 1,000 isolates of bacteroides fragilis group: effect of the medium on test results.
Snydman DR; Jacobus NV; McDermott LA; Supran SE
Antimicrob Agents Chemother; 2000 Jun; 44(6):1710-2. PubMed ID: 10817736
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of the Bacteroides fragilis group to newer quinolones and other standard anti-anaerobic agents.
Horn R; Robson HG
J Antimicrob Chemother; 2001 Jul; 48(1):127-30. PubMed ID: 11418523
[TBL] [Abstract][Full Text] [Related]
6. gyrA mutations associated with quinolone resistance in Bacteroides fragilis group strains.
Oh H; El Amin N; Davies T; Appelbaum PC; Edlund C
Antimicrob Agents Chemother; 2001 Jul; 45(7):1977-81. PubMed ID: 11408211
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin.
Bauernfeind A
J Antimicrob Chemother; 1997 Nov; 40(5):639-51. PubMed ID: 9421311
[TBL] [Abstract][Full Text] [Related]
8. Single- and multistep selection study of the antipneumococcal activity of BMS-284756 compared to ciprofloxacin, levofloxacin, trovafloxacin and moxifloxacin.
Clark CL; Nagai K; Davies TA; Bozdogan B; Dewasse B; Jacobs MR; Appelbaum PC
Clin Microbiol Infect; 2002 Jun; 8(6):373-80. PubMed ID: 12084107
[TBL] [Abstract][Full Text] [Related]
9. Comparative activities of clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, ofloxacin, sparfloxacin, and trovafloxacin and nonquinolones linozelid, quinupristin-dalfopristin, gentamicin, and vancomycin against clinical isolates of ciprofloxacin-resistant and -susceptible Staphylococcus aureus strains.
Jones ME; Visser MR; Klootwijk M; Heisig P; Verhoef J; Schmitz FJ
Antimicrob Agents Chemother; 1999 Feb; 43(2):421-3. PubMed ID: 9925551
[TBL] [Abstract][Full Text] [Related]
10. Comparative bactericidal activities of ciprofloxacin, clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, and trovafloxacin against Streptococcus pneumoniae in a dynamic in vitro model.
Klepser ME; Ernst EJ; Petzold CR; Rhomberg P; Doern GV
Antimicrob Agents Chemother; 2001 Mar; 45(3):673-8. PubMed ID: 11181341
[TBL] [Abstract][Full Text] [Related]
11. Comparative activity of moxifloxacin in vitro against obligately anaerobic bacteria.
Ackermann G; Schaumann R; Pless B; Claros MC; Goldstein EJ; Rodloff AC
Eur J Clin Microbiol Infect Dis; 2000 Mar; 19(3):228-32. PubMed ID: 10795599
[TBL] [Abstract][Full Text] [Related]
12. Fluoroquinolone resistance in Bacteroides fragilis following sparfloxacin exposure.
Peterson ML; Hovde LB; Wright DH; Hoang AD; Raddatz JK; Boysen PJ; Rotschafer JC
Antimicrob Agents Chemother; 1999 Sep; 43(9):2251-5. PubMed ID: 10471574
[TBL] [Abstract][Full Text] [Related]
13. In vitro activities of six fluoroquinolones against Canadian isolates of vancomycin-sensitive and vancomycin-resistant Enterococcus species.
Zhanel GG; Karlowsky JA; Hoban DJ
Diagn Microbiol Infect Dis; 1998 Jun; 31(2):343-7. PubMed ID: 9635908
[TBL] [Abstract][Full Text] [Related]
14. Comparative activities of eight quinolones against members of the Bacteroides fragilis group.
Borobio MV; Conejo M; Ramirez E; Suarez AI; Perea EJ
Antimicrob Agents Chemother; 1994 Jun; 38(6):1442-5. PubMed ID: 8092852
[TBL] [Abstract][Full Text] [Related]
15. Activities of garenoxacin (BMS-284756) and other agents against anaerobic clinical isolates.
Hecht DW; Osmolski JR
Antimicrob Agents Chemother; 2003 Mar; 47(3):910-6. PubMed ID: 12604521
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial susceptibility patterns for recent clinical isolates of anaerobic bacteria in South Korea.
Lee Y; Park Y; Kim MS; Yong D; Jeong SH; Lee K; Chong Y
Antimicrob Agents Chemother; 2010 Sep; 54(9):3993-7. PubMed ID: 20585132
[TBL] [Abstract][Full Text] [Related]
17. [Bactericidal activity of Trovafloxacin and Moxifloxacin against Gram-negative anaerobic bacilli].
Bosnea D; Stadoleanu C; Boswell FJ; Buiuc D
Rev Med Chir Soc Med Nat Iasi; 2000; 104(4):117-22. PubMed ID: 12089939
[TBL] [Abstract][Full Text] [Related]
18. In vitro potency of moxifloxacin, clinafloxacin and sitafloxacin against 248 genetically defined clinical isolates of Staphylococcus aureus.
Schmitz FJ; Fluit AC; Milatovic D; Verhoef J; Heinz HP; Brisse S
J Antimicrob Chemother; 2000 Jul; 46(1):109-13. PubMed ID: 10882698
[TBL] [Abstract][Full Text] [Related]
19. Comparative activities of ciprofloxacin, clinafloxacin, gatifloxacin, gemifloxacin, levofloxacin, moxifloxacin, and trovafloxacin against epidemiologically defined Acinetobacter baumannii strains.
Heinemann B; Wisplinghoff H; Edmond M; Seifert H
Antimicrob Agents Chemother; 2000 Aug; 44(8):2211-3. PubMed ID: 10898706
[TBL] [Abstract][Full Text] [Related]
20. Comparative activity of trovafloxacin and Bay 12-8039 against 452 clinical isolates of Streptococcus pneumoniae.
Weiss K; Laverdiere M; Restieri C
J Antimicrob Chemother; 1998 Oct; 42(4):523-5. PubMed ID: 9818753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
